These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12963898)

  • 41. Adapalene gel 0.1%: effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients.
    Zhu XJ; Tu P; Zhen J; Duan YQ
    Cutis; 2001 Oct; 68(4 Suppl):55-9. PubMed ID: 11845949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients.
    Jacyk WK; Mpofu P
    Cutis; 2001 Oct; 68(4 Suppl):48-54. PubMed ID: 11845948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents.
    Brand B; Gilbert R; Baker MD; Poncet M; Greenspan A; Georgeian K; Soloff AM
    J Am Acad Dermatol; 2003 Sep; 49(3 Suppl):S227-32. PubMed ID: 12963899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study.
    Fleischer AB; Shalita A; Eichenfield LF; Abramovits W; Lucky A; Garrett S;
    J Drugs Dermatol; 2010 Jan; 9(1):33-40. PubMed ID: 20120423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
    Tanghetti E; Dhawan S; Green L; Del Rosso J; Draelos Z; Leyden J; Shalita A; Glaser DA; Grimes P; Webster G; Barnett P; Le Gall N
    J Drugs Dermatol; 2010 May; 9(5):549-58. PubMed ID: 20480800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
    Weiss J; Stein Gold L; Leoni M; Rueda MJ; Liu H; Tanghetti E
    J Drugs Dermatol; 2015 Dec; 14(12):1427-35. PubMed ID: 26659936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris.
    Pariser DM; Westmoreland P; Morris A; Gold MH; Liu Y; Graeber M
    J Drugs Dermatol; 2007 Sep; 6(9):899-905. PubMed ID: 17941361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial.
    Thiboutot D; Pariser DM; Egan N; Flores J; Herndon JH; Kanof NB; Kempers SE; Maddin S; Poulin YP; Wilson DC; Hwa J; Liu Y; Graeber M;
    J Am Acad Dermatol; 2006 Feb; 54(2):242-50. PubMed ID: 16443054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients.
    Clucas A; Verschoore M; Sorba V; Poncet M; Baker M; Czernielewski J
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S116-8. PubMed ID: 9204089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.
    Gold LS; Cruz A; Eichenfield L; Tan J; Jorizzo J; Kerrouche N; Dhuin JC
    Cutis; 2010 Feb; 85(2):94-104. PubMed ID: 20349684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adapalene in the treatment of African patients.
    Jacyk WK
    J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():37-42. PubMed ID: 11843232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.
    Leyden JJ; Shalita A; Thiboutot D; Washenik K; Webster G
    Clin Ther; 2005 Feb; 27(2):216-24. PubMed ID: 15811485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life.
    Grosshans E; Marks R; Mascaro JM; Torras H; Meynadier J; Alirezai M; Finlay AY; Soto P; Poncet M; Verschoore M; Clucas A
    Br J Dermatol; 1998 Oct; 139 Suppl 52():26-33. PubMed ID: 9990418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is switching retinoids a sound strategy for the treatment of acne vulgaris?
    Gold LS; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s11-7. PubMed ID: 18575221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies.
    Eichenfield LF; Jarratt M; Schlessinger J; Kempers S; Manna V; Hwa J; Liu Y; Graeber M;
    J Drugs Dermatol; 2010 Jun; 9(6):639-46. PubMed ID: 20645525
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multicenter efficacy and tolerability evaluation of benzoyl peroxide in a 10% urea vehicle for the treatment of acne vulgaris.
    Gold MH
    J Drugs Dermatol; 2006 May; 5(5):442-5. PubMed ID: 16703780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial.
    Prasad S; Mukhopadhyay A; Kubavat A; Kelkar A; Modi A; Swarnkar B; Bajaj B; Vedamurthy M; Sheikh S; Mittal R
    Indian J Dermatol Venereol Leprol; 2012; 78(4):459-67. PubMed ID: 22772617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymecycline in the treatment of acne: an efficacious, safe and cost-effective alternative to minocycline.
    Bossuyt L; Bosschaert J; Richert B; Cromphaut P; Mitchell T; Al Abadie M; Henry I; Bewley A; Poyner T; Mann N; Czernielewski J
    Eur J Dermatol; 2003; 13(2):130-5. PubMed ID: 12695127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: Effective Acne Therapy Regardless of Age or Gender.
    Stein Gold L; Werschler WP; Mohawk J
    J Drugs Dermatol; 2017 Jun; 16(6):582-589. PubMed ID: 28686776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.